550 related articles for article (PubMed ID: 17456574)
21. Second-tier Testing for 21-Hydroxylase Deficiency in the Netherlands: A Newborn Screening Pilot Study.
Stroek K; Ruiter A; van der Linde A; Ackermans M; Bouva MJ; Engel H; Jakobs B; Kemper EA; van den Akker ELT; van Albada ME; Bocca G; Finken MJJ; Hannema SE; Mieke Houdijk ECA; van der Kamp HJ; van Tellingen V; Paul van Trotsenburg AS; Zwaveling-Soonawala N; Bosch AM; de Jonge R; Heijboer AC; Claahsen-van der Grinten HL; Boelen A
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4487-e4496. PubMed ID: 34171085
[TBL] [Abstract][Full Text] [Related]
22. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
[TBL] [Abstract][Full Text] [Related]
23. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
Zhang Q; Wang B; Chen Y; Jiang D; Chen Y
Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):706-9. PubMed ID: 25476436
[TBL] [Abstract][Full Text] [Related]
24. Advancement in steroid hormone analysis by LC-MS/MS in clinical routine diagnostics - A three year recap from serum cortisol to dried blood 17α-hydroxyprogesterone.
Gaudl A; Kratzsch J; Ceglarek U
J Steroid Biochem Mol Biol; 2019 Sep; 192():105389. PubMed ID: 31158444
[TBL] [Abstract][Full Text] [Related]
25. A case of 11beta-hydroxylase deficiency detected in a newborn screening program by second-tier LC-MS/MS.
Peter M; Janzen N; Sander S; Korsch E; Riepe FG; Sander J
Horm Res; 2008; 69(4):253-6. PubMed ID: 18204274
[TBL] [Abstract][Full Text] [Related]
26. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
[TBL] [Abstract][Full Text] [Related]
27. Comparison of different preparation techniques of dried blood spot quality controls in newborn screening for congenital adrenal hyperplasia.
Grecsó N; Zádori A; Baráth Á; Galla Z; Rácz G; Bereczki C; Monostori P
PLoS One; 2021; 16(5):e0252091. PubMed ID: 34015037
[TBL] [Abstract][Full Text] [Related]
28. Implementing steroid profiling by liquid chromatography-tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand.
de Hora MR; Heather NL; Patel T; Bresnahan LG; Webster D; Hofman PL
Clin Endocrinol (Oxf); 2021 Jun; 94(6):904-912. PubMed ID: 33471388
[TBL] [Abstract][Full Text] [Related]
29. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
[TBL] [Abstract][Full Text] [Related]
30. Hormonal disturbances due to severe and mild forms of congenital adrenal hyperplasia are already detectable in neonatal life.
Faurschou S; Mouritsen A; Johannsen TH; Hougaard DM; Cohen A; Duno M; Juul A; Main KM
Acta Paediatr; 2015 Feb; 104(2):e57-62. PubMed ID: 25346389
[TBL] [Abstract][Full Text] [Related]
31. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
Güran T; Tezel B; Gürbüz F; Selver Eklioğlu B; Hatipoğlu N; Kara C; Şimşek E; Çizmecioğlu FM; Ozon A; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):13-23. PubMed ID: 30111524
[TBL] [Abstract][Full Text] [Related]
32. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
Gatelais F; Berthelot J; Beringue F; Descamps P; Bonneau D; Limal JM; Coutant R
Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
[TBL] [Abstract][Full Text] [Related]
33. Multiplexed steroid profiling of gluco- and mineralocorticoids pathways using a liquid chromatography tandem mass spectrometry method.
Travers S; Martinerie L; Bouvattier C; Boileau P; Lombès M; Pussard E
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):202-211. PubMed ID: 27339652
[TBL] [Abstract][Full Text] [Related]
34. Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiency.
Kösel S; Burggraf S; Fingerhut R; Dörr HG; Roscher AA; Olgemöller B
Clin Chem; 2005 Feb; 51(2):298-304. PubMed ID: 15608154
[TBL] [Abstract][Full Text] [Related]
35. Automated, fast and sensitive quantification of 17 alpha-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction.
Rauh M; Gröschl M; Rascher W; Dörr HG
Steroids; 2006 Jun; 71(6):450-8. PubMed ID: 16569417
[TBL] [Abstract][Full Text] [Related]
36. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia.
Mitchell ML; Hermos RJ
Clin Endocrinol (Oxf); 1998 Jun; 48(6):757-60. PubMed ID: 9713565
[TBL] [Abstract][Full Text] [Related]
37. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
38. Changes of several adrenal delta 4-steroids measured by HPLC-UV spectrometry in neonatal patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Saisho S; Shimozawa K; Yata J
Horm Res; 1990; 33(1):27-34. PubMed ID: 2376395
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a bracketing calibration-based isotope dilution liquid chromatography-tandem mass spectrometry candidate reference measurement procedure for 17α-hydroxyprogesterone in human plasma.
Zhang Q; Zhang L; Lin H; Cai Z; Yan J; Wang Q; Han L; Wang J; Ke P; Zhuang J; Huang X
Anal Bioanal Chem; 2019 Nov; 411(27):7095-7104. PubMed ID: 31673753
[TBL] [Abstract][Full Text] [Related]
40. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants.
Güran T; Tezel B; Çakır M; Akıncı A; Orbak Z; Keskin M; Selver Eklioğlu B; Ozon A; Özbek MN; Karagüzel G; Hatipoğlu N; Gürbüz F; Çizmecioğlu FM; Kara C; Şimşek E; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):287-294. PubMed ID: 32157855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
